DC
David J Collier

David J Collier insider trades: Menlo Therapeutics (MNLO) stock buys and sales

Menlo Therapeutics Last trade Jul 24, 2018 14 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2013
5
Companies
last trade 2018

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where David reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 24, 2018MNLO↓ Sell$3.7M
Jul 24, 2018MNLO↓ Sell$96K
Apr 20, 2016NEOS↓ Sell$198K
Apr 20, 2016NEOS↓ Sell$5K
Apr 15, 2016NEOS↓ Sell$578K
Apr 15, 2016NEOS↓ Sell$15K
Nov 10, 2014IMI↓ Sell$9.9M
Nov 10, 2014CDXS↓ Sell$6.9M
Mar 20, 2014IMI↓ Sell$125K
Sep 18, 2013TTPH↓ Sell$1.0M
Sep 17, 2013TTPH↓ Sell$495K
Mar 25, 2013TTPH↑ Buy$4.5M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About David J Collier's insider trades

David J Collier is an insider at Menlo Therapeutics (MNLO). Since Mar 25, 2013, David has reported 1 open-market purchase worth $4.5M and 11 sales worth $23.0M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include conversions (5 filings), other transactions (3 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MNLO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.